Rituximab and abatacept but not tocilizumab impair antibody response to ... 7thSpace Interactive (press release) IntroductionThe objective of the study was to investigate the impact of newer biologic treatments including rituximab, abatacept and tocilizumab on antibody response following pneumococcal vaccination using a 7-valent conjugate vaccine in patients with ... |
